About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Advanced Enzyme Technologies Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
540025
ISIN Demat
INE837H01020
Book Value
61.14
NSE Code
ADVENZYMES
Dividend Yield %
1.77
Market Cap
32945.65
P/E
27.33
EPS
10.77
Face Value
2
BSE
NSE
05-Mar-2026
BSE
NSE
NSE F & O
05-Mar-2026
BSE
NSE
NSE F & O
Last Price
294.35
Net Change
10.1
% Change
3.55%
Prev.Close
284.25
Open
284.60
High
297.60
Low
283.75
Volume
4598
Last Price
295.25
Net Change
10.55
% Change
3.71%
Prev.Close
284.70
Open
284.20
High
299.30
Low
284.15
Volume
161566
Value
1341706
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
297.60
52-Week High
366.55
52-Week Low
259.70
Value
47532272.75
Best Buy
295.25
Best Sell
0.00
Best Quantity
1
Sell Quantity
0
Today's Range
299.30
52-Week High
366.25
52-Week Low
259.00
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
1
Price
295.25
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Book Closure
11-Jul-20
15-Jul-20
Dividend
60 %
23-Jul-25
Company News
15-01-2026
Advanced Enzyme Technolog...
26-12-2025
Advanced Enzyme Technolog...
07-10-2025
Advanced Enzyme Technolo...
12-03-2025
Advanced Enzyme Technolog...
19-12-2024
Advanced Enzyme Technolog...
16-12-2024
Advanced Enzyme Technolog...
05-12-2024
Advanced Enzyme Technolog...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.